Oleanolic acid attenuates morphine withdrawal symptoms in rodents: Association with regulation of dopamine function

8Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Introduction: Oleanolic acid (OA) has been shown to be useful for the treatment of mental disorders. Methods: In this study, we investigated the effects of OA in animal models of spontaneous withdrawal and naloxone-precipitated withdrawal and evaluated the effects of OA on the acquisition, extinction, and reinstatement of morphine-induced conditioned place preference (CPP). Results: OA significantly improved symptoms of withdrawal, and significantly reduced the acquisition and reinstatement of morphine-induced conditioned place preference. Moreover, OA significantly reduced the serum content of 5-hydroxy tryptamine (5-HT) and dopamine (DA) in a dose-dependent manner, and reduced norepinephrine (NE) and 5-HT content in the frontal cortex (PFC), while significantly increasing endorphin content in rats. OA also significantly reduced serum DA content in mice. Conclusion: These results indicate that OA can improve the withdrawal symptoms of rats and mice by regulating the DA system and suggest that OA may be useful in treatment of morphine addiction.

Author supplied keywords

Cite

CITATION STYLE

APA

Shi, Z., Pan, S., Wang, L., & Li, S. (2021). Oleanolic acid attenuates morphine withdrawal symptoms in rodents: Association with regulation of dopamine function. Drug Design, Development and Therapy, 15, 3685–3696. https://doi.org/10.2147/DDDT.S326583

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free